This publication offers practical guidance to EU/EEA countries, encouraging them to transition from emergency surveillance for COVID-19 to more sustainable, objective-driven, surveillance systems.
This document describes the project Analysis of COVID 19 contact tracing data conducted between September 2020 and April 2021 as part of the European Programme for Intervention Epidemiology Training (EPIET) EPIET), coordinated by ECDC.
This report provides updated 30-day projections, together with the inherent model assumptions and uncertainties. Both the model projections and the data to which the model is calibrated should be interpreted with caution given the differences between national surveillance systems, case definitions and testing policies. Comparisons between countries based on the data and forecasts presented in this paper should only be made with extreme caution and should take these differences into account. Nonetheless, the projections presented here illustrate potential future trends in COVID-19 transmission in EU/EEA countries and the UK.
This report provides an updated overview on the progress of national COVID-19 vaccination strategies and deployment in European Union/European Economic Area (EU/EEA) countries, including updates on overall vaccine uptake and uptake by target group and vaccination strategies and policies.
This report presents the results of a study that dealt specifically with effective communication around the benefit and risk balance of vaccination people’s risk perceptions around vaccines and diseases, and approaches to enhancing communication about the safety and effectiveness of vaccines.
In an effort to continuously improve its performance, the Centre commissioned an external assessment of its response to the COVID-19 pandemic for the period January - September 2020. The report was presented to ECDC Management Board meeting 25 November 2020 with specific focus on its 26 recommendations, and is currently used as a basis for an action plan defined by ECDC management.
This report presents surveillance data on Clostridioides (Clostridium) difficile infection (CDI) in acute care hospitals in European Union/European Economic Area (EU/EEA) countries, the UK, and Serbia.
In this update, we analyse the risk posed to the general population, vulnerable individuals, and healthcare provision by the current increase in COVID-19 case notification rates observed in the EU/EEA and the UK.
This protocol presents a common methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating EU/EEA Member States.